APA Chose Canadian Site as Field Trial Site for DSM-5

Recommend to others!

The Canadian site, CAMH (Centre for Addiction and Mental Health) has been selected by APA (the American Psychiatric Association’s) as one of the seventh adult field trial sites in North America for its fifth edition of the DSM (Diagnostic and Statistical Manual of Mental Disorders). DSM is the manual which is used by global health professionals to study descriptions, symptoms and other criteria for analyzing and diagnosing mental disorders.

Dr. Michael Bagby, Director of Clinical Research at CAMH said that CAMH’s selection as one of the field trial sites to test proposed diagnostic criteria for APA’s DSM-5 is an honor for it. He sees this honor as CAMH’s contribution in medical research especially in the field of psychiatry and mental disorders.
APA went through a competitive ordeal in selection of 65 submitted proposals from different organizations to consider for a field trial site. CAMH was the only site to have been chosen among 11 handpicked organizations.

Drs. Bruce Pollock, Michael Bagby and Kwame McKenzie are among those dignitaries who will be gracing the field trials to be held at CAMH. At the site, there will be discussions on mental disorders like schizoaffective disorder, schizophrenia, paranoid personality disorders and attenuated psychotic symptoms syndrome. Further, in the field trial, participant clinicians will assess the new and existing patients who are undergoing at different stages of treatments with the help of projected DSM -5 diagnostic criteria and assessment.

Further, the field trials will test new tools which assist clinicians evaluate the overall medical symptoms and to recuperations of patients including cross cutting dimensional measurements which measures insomniac type of symptoms which take place across comprehensive diagnosis.

Comments

comments

Speak Your Mind

*

Current day month ye@r *